Boston Center for Memory (BCM) was established in 2012 following the recognition by a group of Alzheimer's disease experts that a full time multi-specialty clinical center was needed within the Boston area.

 

BCM is structured to provide patients with Mild Cognitive Impairment, Alzheimer's disease, and related dementias, a timely and comprehensive evaluation, an accurate diagnosis, and a treatment plan and follow up care that meets each patient’s needs.

​

To best serve our patients and to provide quality care and treatment options for our patients with memory problems, we offer a comprehensive support system that incorporates behavioral neurology, clinical neuropsychology, and geriatric psychiatry. Our patients’ dignity and privacy are paramount and are protected with the utmost vigilance. We strive to provide an atmosphere that ensures comfort for our patients and their families.

 

Over the past decade, the efforts of the Alzheimer’s disease community have contributed to scientific advancements including new methods of screening, improved diagnostic techniques, as well as FDA approved safe and effective treatments, thus greatly improving the quality of life for our patients and their families. We are dedicated to continuing our efforts until Alzheimer’s disease is a disease that is prevented from affecting lives. We hope that our current efforts will continue to result in improved patient outcomes and quality of life in the future.

​

The staff at Boston Center for Memory has collectively published more than 300 books, chapters, and papers and has had over 40,000 encounters with patients and families with Mild Cognitive Impairment, Alzheimer's disease, and related dementias. 

 

Boston Center for Memory's core mission is to provide: 1) education for patient's, families/caregivers, and professionals 2) multi-specialty treatment utilizing a treatment team approach 3) follow up care to meet the patients and family/caregiver's needs, and 4) research to provide better diagnostics for detection and better treatments for patients with Mild Cognitive Impairment, Alzheimer's disease, and related dementias.